Praeventix
Exton
About Praeventix
Praeventix is an early-stage biotechnology company developing therapeutics to treat bowel diseases. It engages in and focuses on the discovery, research, and early clinical development of novel serotonergic therapeutics with potential applications in dermatologic, autoimmune, and neurodegenerative diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $14.1M
- Last round: Series Unknown (Feb 2026)
- Website: praeventix.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/praeventix-111210 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.